Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Showing results for

The University of Oxford and Sound Pharmaceuticals completed this new Phase 2a study testing SPI-1005, an investigational drug that contains ebselen, as a new treatment for bipolar disorder.

Trees in the shape of two heads, one with green leaves in blue sky and the other with empty branches in grey sky.

Polly Waite

DClinPsy, PhD Polly Waite - Associate Professor of Clinical Psychology, Deputy Director of the Oxford Centre for Emerging Minds Research

Claire Gregory

Claire Gregory

Jeremy Hall

Jeremy Hall

Pauline Brandt

Pauline Brandt

Emma Lawrance

Emma Lawrance

Bethany Linder

Bethany Linder

Ryad Chems-Maarid

PhD Ryad Chems-Maarid - Postdoctoral Researcher

Lea Francia

Lea Francia

Connor Keating

BSc, PhD Connor Keating - PAUL FOUNDATION RESEARCH FELLOW

Hannah Briar

Hannah Briar - Research Clinic Administrator: Depression Research Centre

Sarah Bauermeister

PhD, CPsychol, AFBPsS, MSc, BSc Hons, BA Hons Sarah Bauermeister - Associate Professor, PI Life Course Cognitive Health, Co-Director BrainWaves

Ankita Ganesh

Ankita Ganesh - HR Officer - Oxford Centre for Emerging Minds Research

Nishat Tahira

Nishat Tahira

William Pettersson-Yeo

William Pettersson-Yeo

Keya Bergeron-Verma

Keya Bergeron-Verma

Yong Wang

Yong Wang

Sarah Clayton

Sarah Clayton

Hollis du Pont

Hollis du Pont - MSc in Neuroscience student

Emma Scholey

PhD Emma Scholey - Postdoctoral Research Associate

Nimra Khan

Nimra Khan

Load More

1
2
3
4
5
6
7
...
»